Related Experiment Videos
Pulmonary abnormalities caused by interferon with or without herbal drug: CT and radiographic findings
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica
|February 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dose escalation study of carboplatin-pemetrexed followed by maintenance pemetrexed for elderly patients with advanced nonsquamous nonsmall-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
Effect of topotecan as second-line chemotherapy for small cell lung cancer patients with interstitial lung disease.
Journal of chemotherapy (Florence, Italy)·2012
Dual beat-frequencies laser Doppler interferometer.
The Review of scientific instruments·2012
[Repair of Ebstein's anomaly in an elderly patient; report of a case].
Kyobu geka. The Japanese journal of thoracic surgery·2008
[Bilateral massive ovarian edema: a case report including MR findings and etiology].
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·2005
[Uterine artery embolization using gelatin sponge in a miniature pig: a study of arterial size and the distribution of embolic materials].
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·2005
[In-vitro phantoms for estimating diffusion tensor tractography].
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·2005
[Radionuclide cisternography for patients suspected of having intracranial hypotension].
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·2005
[Prediction of pelvic control using MRI for patients with cervical carcinoma treated with radiotherapy].
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·2005
[Experience of brachytherapy using I-125 seed permanent implants for localized prostate cancer].
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·2005
Phloretin Modulates STING Ubiquitination Degradation to Restrain Dendritic Cell Overactivation and Alleviate Sjögren's Syndrome.
Pharmaceuticals (Basel, Switzerland)·2026